Abstract: The present invention provides a multilayer film for forming medical solution pouches that help prevent or reduce the presence of bubbles or foam in the solution after heat sterilization. In particular, the present invention provides a multilayer film for forming medical solution pouches that are capable of passing the bubble test as set forth in the Chinese State Drug Package Container Material Standard No. YBB00112005. In particular, the present invention provides a multilayer film in which polyamide 612 or calcium stearate component has been incorporated as an anti-foaming agent. The presence of polyamide 612 or calcium stearate in one or more layers of the film helps prevent the formation of foam in the solution after heat sterilization.

Abstract: The present invention provides a multilayer film for forming medical solution pouches that help prevent or reduce the presence of bubbles or foam in the solution after heat sterilization. In particular, the present invention provides a multilayer film for forming medical solution pouches that are capable of passing the bubble test as set forth in the Chinese State Drug Package Container Material Standard No. YBB00112005. In particular, the present invention provides a multilayer film in which polyamide 612 or calcium stearate component has been incorporated as an anti-foaming agent. The presence of polyamide 612 or calcium stearate in one or more layers of the film helps prevent the formation of foam in the solution after heat sterilization.

Abstract: The present invention provides a multilayer film for forming medical solution pouches that help prevent or reduce the presence of bubbles or foam in the solution after heat sterilization. In particular, the present invention provides a multilayer film for forming medical solution pouches that are capable of passing the bubble test as set forth in the Chinese State Drug Package Container Material Standard No. YBB00112005. In particular, the present invention provides a multilayer film in which polyamide 612 or calcium stearate component has been incorporated as an anti-foaming agent. The presence of polyamide 612 or calcium stearate in one or more layers of the film helps prevent the formation of foam in the solution after heat sterilization.

Abstract: The present invention provides a multilayer film for forming medical solution pouches that help prevent or reduce the presence of bubbles or foam in the solution after heat sterilization. In particular, the present invention provides a multilayer film for forming medical solution pouches that are capable of passing the bubble test as set forth in the Chinese State Drug Package Container Material Standard No. YBB00112005. In particular, the present invention provides a multilayer film in which polyamide 612 or calcium stearate component has been incorporated as an anti-foaming agent. The presence of polyamide 612 or calcium stearate in one or more layers of the film helps prevent the formation of foam in the solution after heat sterilization.

Abstract: The invention is a method of measuring oxygen concentration in a package having an oxygen sensitive product disposed therein. The method includes exposing a luminescent compound that is disposed in an interior of the package to light having a wavelength that is absorbed by the luminescent compound so that the luminescent compound is promoted into an excited state. When the exposure of the light is terminated, the excited luminescent compound emits light that is detectable by a detector positioned outside of the package. The intensity of the emitted light is inversely proportional to the oxygen concentration and is used in conjunction with mathematical function that describes the luminescent intensity of the luminescent compound as a function of oxygen concentration and temperature to calculate the oxygen concentration. The method may be used to verify and track the oxygen concentration of a package as it moves through a distribution system.

Abstract: The invention is a UV sensitive composition that undergoes a color change upon exposure to a predetermined dosage of UV-C radiation. The UV-C sensitive composition comprises a halogenated polymer, such as polyvinylidene chloride, that produces an acid upon exposure to UV radiation, and a pH sensitive dye. Upon exposure to UV-C radiation, the halogenated polymer undergoes degradation and produces HCl. The pH sensitive dye changes color as a result in an increase in HCl in the system. The composition may also include an acid scavenging composition and/or a diluent to control the amount of HCl produced in the system. The amount of HCl liberated from UV-C exposure may be selectively controlled so that a color change may be produced at a desired UV-C dosage. In some embodiments, the composition may be used to indicate a UV-C dosage from about 100 to 1600 mJ/cm2.

Abstract: An apparatus and non-invasive method of measuring oxygen by exciting a luminescent compound disposed in a container and then measuring the intensity of the light emitted by the excited luminescent compound as it relaxes to the ground state. A plot of emission intensity as a function of time results in an exponential decay curve the area of which is inversely proportional to the oxygen concentration. The oxygen concentration can be determined over a wide temperature range by measuring the temperature of the container and the emission intensity and then applying the following equation: [O2]=(ATa(T)2+BTa(T)+CTa)(tau)2+(ATb(T)2+BTb(T)+CTb)(tau)+(ATc(T)2+BTc(T)+CTc) T is the measured temperature; tau is the area of the exponential decay curve; and ATa, BTa, CTa, ATb, BTb, CTb, ATc, BTc, and CTc are coefficients that are specific to the luminescent compound being examined.

Abstract: An apparatus for heat shrinking of a heat-shrinkable thermoplastic film that is used to package a product by passing the product packaged in the film through a rotatable shrink tunnel with a heated transfer medium passing through the tunnel to cause the shrinkage of the wrap material.